Matthew Craig Kapusta
Net Worth
Last updated:
What is Matthew Craig Kapusta net worth?
The estimated net worth of Mr. Matthew Craig Kapusta is at least $28,116,138 as of 10 Dec 2024. He owns shares worth $9,136,141 as insider, has earned $12,221,637 from insider trading and has received compensation worth at least $6,758,360 in uniQure N.V..
What is the salary of Matthew Craig Kapusta?
Mr. Matthew Craig Kapusta salary is $965,480 per year as Chief Executive Officer & Executive Director in uniQure N.V..
How old is Matthew Craig Kapusta?
Mr. Matthew Craig Kapusta is 53 years old, born in 1972.
What stocks does Matthew Craig Kapusta currently own?
As insider, Mr. Matthew Craig Kapusta owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| uniQure N.V. (QURE) | Chief Executive Officer & Executive Director | 597,915 | $15.28 | $9,136,141 |
What does uniQure N.V. do?
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy that is in Phase I/II clinical study for the treatment of Huntington's disease; AMT-060, which is in Phase I/II clinical trial for the treatment of hemophilia B; AMT-210, a product candidate for the treatment of Parkinson's disease; AMT-260 for temporal lobe epilepsy; AMT-240, a preclinical product candidate for the treatment of autosomal dominant Alzheimer's disease; and AMT-161 for the treatment of amyotrophic lateral sclerosis. uniQure N.V. was founded in 1998 and is headquartered in Amsterdam, the Netherlands.
Matthew Craig Kapusta insider trading
uniQure N.V.
Mr. Matthew Craig Kapusta has made 66 insider trades between 2018-2024, according to the Form 4 filled with the SEC.
The largest trade he's ever made was exercising 100,000 units of QURE stock on 10 Dec 2024. As of 10 Dec 2024 he still owns at least 597,915 units of QURE stock.
uniQure N.V. key executives
uniQure N.V. executives and other stock owners filed with the SEC:
- Dr. Alexander E. Kuta Ph.D. (65) Executive Vice President of Quality & Regulatory
- Dr. Ricardo Dolmetsch Ph.D. (56) Pres of R&D
- Mr. Christian Klemt (52) Chief Financial Officer, Principal Financial Officer & GM of Amsterdam Site
- Mr. Matthew Craig Kapusta (53) Chief Executive Officer & Executive Director